{"id":127441,"date":"2022-02-02T11:14:36","date_gmt":"2022-02-02T04:14:36","guid":{"rendered":"https:\/\/nawacita.co\/?p=127441"},"modified":"2022-02-02T11:14:36","modified_gmt":"2022-02-02T04:14:36","slug":"bpom-terbitkan-izin-penggunaan-vaksin-sinopharm-sebagai-vaksin-booster","status":"publish","type":"post","link":"https:\/\/nawacita.co\/index.php\/2022\/02\/02\/bpom-terbitkan-izin-penggunaan-vaksin-sinopharm-sebagai-vaksin-booster\/","title":{"rendered":"BPOM Terbitkan Izin Penggunaan Vaksin Sinopharm Sebagai Vaksin Booster"},"content":{"rendered":"<p><strong>Jakarta, Nawacita<\/strong> | Sinopharm resmi menjadi vaksin keenam yang digunakan untuk dosis booster atau penguat di Indonesia. Badan Pengawas Obat dan Makanan (BPOM) menerbitkan Izin Penggunaan Darurat (Emergency Use Authorization\/EUA).<\/p>\n<p>&#8220;Sesuai persyaratan penggunaan darurat, BPOM telah melakukan evaluasi terhadap aspek khasiat dan keamanan mengacu pada standar evaluasi vaksin COVID-19 untuk vaksin Sinopharm sebagai dosis booster homolog untuk dewasa 18 tahun ke atas,\u201d ujar Kepala BPOM Penny K Lukito melalui pernyataan tertulis yang diterima di Jakarta, Rabu (2\/2\/2022).<\/p>\n<p>Vaksin dengan nama SARS-CoV-2 Vaccine (Vero Cell), Inactivated, produksi Beijing Bio-Institute Biological, China atau dikenal sebagai vaksin Sinopharm telah didaftarkan PT Kimia Farma untuk penggunaan booster homolog pada usia dewasa 18 tahun atau lebih yang telah mendapatkan dosis primer lengkap minimal enam bulan sebelumnya.<\/p>\n<p>Berdasarkan aspek keamanan, kata Penny, penggunaan vaksin Sinopharm sebagai booster umumnya dapat ditoleransi dengan baik. Frekuensi, jenis, dan keparahan reaksi sampingan atau kejadian yang tidak diharapkan setelah pemberian booster lebih rendah dibandingkan saat pemberian dosis primer.<\/p>\n<p>Berdasarkan kajian aspek imunogenisitas, terjadi peningkatan respons imun humoral untuk parameter pengukuran antibodi netralisasi dan anti-IgG masing-masing sebesar 8,4 kali dan 8 kali lipat dibandingkan sebelum pemberian booster. Ia mengatakan respons imun setelah pemberian booster vaksin Sinopharm lebih tinggi dibandingkan respons imun yang dihasilkan pada saat vaksinasi primer.<\/p>\n<p>\u201cPersetujuan EUA vaksin Sinopharm ini menambah alternatif vaksin booster homologus untuk platform inactivated virus,&#8221; ujarnya.<\/p>\n<p>Penny menyampaikan apresiasi kepada Tim Ahli Komite Nasional Penilai Vaksin COVID-19 termasuk ahli di bidang farmakologi, metodologi penelitian dan statistik, epidemiologi, kebijakan publik, imunologi, ITAGI serta asosiasi klinisi atas kerja sama yang memungkinkan vaksin Sinopharm segera rilis ke masyarakat.<\/p>\n<p>BPOM mengimbau masyarakat untuk selalu menerapkan protokol kesehatan dan menyukseskan vaksinasi sebagai upaya kunci dalam memutus rantai penyebaran COVID-19.<\/p>\n<p>oz.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Jakarta, Nawacita | Sinopharm resmi menjadi vaksin keenam yang digunakan untuk dosis booster atau penguat di Indonesia. Badan Pengawas Obat dan Makanan (BPOM) menerbitkan Izin Penggunaan Darurat (Emergency Use Authorization\/EUA). &#8220;Sesuai persyaratan penggunaan darurat, BPOM telah melakukan evaluasi terhadap aspek khasiat dan keamanan mengacu pada standar evaluasi vaksin COVID-19 untuk vaksin Sinopharm sebagai dosis booster [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":127442,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[15857,28669,27531,40746,35198],"class_list":{"0":"post-127441","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-nasional","8":"tag-bpom","9":"tag-covid-19","10":"tag-terbitkan","11":"tag-vaksin-booster","12":"tag-vaksin-sinopharm"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BPOM Terbitkan Izin Penggunaan Vaksin Sinopharm Sebagai Vaksin Booster - Nawacita<\/title>\n<meta name=\"description\" content=\"Jakarta, Nawacita | Sinopharm resmi menjadi vaksin keenam yang digunakan untuk dosis booster atau penguat di Indonesia. Badan Pengawas Obat\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nawacita.co\/index.php\/2022\/02\/02\/bpom-terbitkan-izin-penggunaan-vaksin-sinopharm-sebagai-vaksin-booster\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BPOM Terbitkan Izin Penggunaan Vaksin Sinopharm Sebagai Vaksin Booster - Nawacita\" \/>\n<meta property=\"og:description\" content=\"Jakarta, Nawacita | Sinopharm resmi menjadi vaksin keenam yang digunakan untuk dosis booster atau penguat di Indonesia. Badan Pengawas Obat\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nawacita.co\/index.php\/2022\/02\/02\/bpom-terbitkan-izin-penggunaan-vaksin-sinopharm-sebagai-vaksin-booster\/\" \/>\n<meta property=\"og:site_name\" content=\"Nawacita\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/nawacitaco-1763136813898723\/?ref=aymt_homepage_panel\" \/>\n<meta property=\"article:published_time\" content=\"2022-02-02T04:14:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nawacita.co\/wp-content\/uploads\/2022\/02\/Sinopharm-Vacc.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"682\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"redaksi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@nawacit4\" \/>\n<meta name=\"twitter:site\" content=\"@nawacit4\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"redaksi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/02\\\/02\\\/bpom-terbitkan-izin-penggunaan-vaksin-sinopharm-sebagai-vaksin-booster\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/02\\\/02\\\/bpom-terbitkan-izin-penggunaan-vaksin-sinopharm-sebagai-vaksin-booster\\\/\"},\"author\":{\"name\":\"redaksi\",\"@id\":\"https:\\\/\\\/nawacita.co\\\/#\\\/schema\\\/person\\\/599683af640858fd3b790bc37828ba57\"},\"headline\":\"BPOM Terbitkan Izin Penggunaan Vaksin Sinopharm Sebagai Vaksin Booster\",\"datePublished\":\"2022-02-02T04:14:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/02\\\/02\\\/bpom-terbitkan-izin-penggunaan-vaksin-sinopharm-sebagai-vaksin-booster\\\/\"},\"wordCount\":283,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nawacita.co\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/02\\\/02\\\/bpom-terbitkan-izin-penggunaan-vaksin-sinopharm-sebagai-vaksin-booster\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nawacita.co\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/Sinopharm-Vacc.jpg\",\"keywords\":[\"BPOM\",\"COVID-19\",\"Terbitkan\",\"vaksin booster\",\"Vaksin Sinopharm\"],\"articleSection\":[\"Nasional\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/02\\\/02\\\/bpom-terbitkan-izin-penggunaan-vaksin-sinopharm-sebagai-vaksin-booster\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/02\\\/02\\\/bpom-terbitkan-izin-penggunaan-vaksin-sinopharm-sebagai-vaksin-booster\\\/\",\"url\":\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/02\\\/02\\\/bpom-terbitkan-izin-penggunaan-vaksin-sinopharm-sebagai-vaksin-booster\\\/\",\"name\":\"BPOM Terbitkan Izin Penggunaan Vaksin Sinopharm Sebagai Vaksin Booster - Nawacita\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nawacita.co\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/02\\\/02\\\/bpom-terbitkan-izin-penggunaan-vaksin-sinopharm-sebagai-vaksin-booster\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/02\\\/02\\\/bpom-terbitkan-izin-penggunaan-vaksin-sinopharm-sebagai-vaksin-booster\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nawacita.co\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/Sinopharm-Vacc.jpg\",\"datePublished\":\"2022-02-02T04:14:36+00:00\",\"description\":\"Jakarta, Nawacita | Sinopharm resmi menjadi vaksin keenam yang digunakan untuk dosis booster atau penguat di Indonesia. Badan Pengawas Obat\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/02\\\/02\\\/bpom-terbitkan-izin-penggunaan-vaksin-sinopharm-sebagai-vaksin-booster\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/02\\\/02\\\/bpom-terbitkan-izin-penggunaan-vaksin-sinopharm-sebagai-vaksin-booster\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/02\\\/02\\\/bpom-terbitkan-izin-penggunaan-vaksin-sinopharm-sebagai-vaksin-booster\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nawacita.co\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/Sinopharm-Vacc.jpg\",\"contentUrl\":\"https:\\\/\\\/nawacita.co\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/Sinopharm-Vacc.jpg\",\"width\":1024,\"height\":682,\"caption\":\"ilustrasi vaksin sinopharm\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/02\\\/02\\\/bpom-terbitkan-izin-penggunaan-vaksin-sinopharm-sebagai-vaksin-booster\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nawacita.co\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BPOM Terbitkan Izin Penggunaan Vaksin Sinopharm Sebagai Vaksin Booster\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nawacita.co\\\/#website\",\"url\":\"https:\\\/\\\/nawacita.co\\\/\",\"name\":\"Nawacita\",\"description\":\"Berita Kementerian, BUMN, Pemerintah dan Politik\",\"publisher\":{\"@id\":\"https:\\\/\\\/nawacita.co\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nawacita.co\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nawacita.co\\\/#organization\",\"name\":\"Nawacita\",\"url\":\"https:\\\/\\\/nawacita.co\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/nawacita.co\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nawacita.co\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/Logo-Nawacita-2021.png\",\"contentUrl\":\"https:\\\/\\\/nawacita.co\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/Logo-Nawacita-2021.png\",\"width\":1676,\"height\":422,\"caption\":\"Nawacita\"},\"image\":{\"@id\":\"https:\\\/\\\/nawacita.co\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/nawacitaco-1763136813898723\\\/?ref=aymt_homepage_panel\",\"https:\\\/\\\/x.com\\\/nawacit4\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nawacita.co\\\/#\\\/schema\\\/person\\\/599683af640858fd3b790bc37828ba57\",\"name\":\"redaksi\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a3ea3038dabe75a981e9a69b300b8272c74e0729c55e2f30478cde7add6c42f6?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a3ea3038dabe75a981e9a69b300b8272c74e0729c55e2f30478cde7add6c42f6?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a3ea3038dabe75a981e9a69b300b8272c74e0729c55e2f30478cde7add6c42f6?s=96&d=mm&r=g\",\"caption\":\"redaksi\"},\"sameAs\":[\"nawacitaportal\",\"https:\\\/\\\/x.com\\\/nawacit4\"],\"url\":\"https:\\\/\\\/nawacita.co\\\/index.php\\\/author\\\/redaksi\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BPOM Terbitkan Izin Penggunaan Vaksin Sinopharm Sebagai Vaksin Booster - Nawacita","description":"Jakarta, Nawacita | Sinopharm resmi menjadi vaksin keenam yang digunakan untuk dosis booster atau penguat di Indonesia. Badan Pengawas Obat","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nawacita.co\/index.php\/2022\/02\/02\/bpom-terbitkan-izin-penggunaan-vaksin-sinopharm-sebagai-vaksin-booster\/","og_locale":"en_US","og_type":"article","og_title":"BPOM Terbitkan Izin Penggunaan Vaksin Sinopharm Sebagai Vaksin Booster - Nawacita","og_description":"Jakarta, Nawacita | Sinopharm resmi menjadi vaksin keenam yang digunakan untuk dosis booster atau penguat di Indonesia. Badan Pengawas Obat","og_url":"https:\/\/nawacita.co\/index.php\/2022\/02\/02\/bpom-terbitkan-izin-penggunaan-vaksin-sinopharm-sebagai-vaksin-booster\/","og_site_name":"Nawacita","article_publisher":"https:\/\/www.facebook.com\/nawacitaco-1763136813898723\/?ref=aymt_homepage_panel","article_published_time":"2022-02-02T04:14:36+00:00","og_image":[{"width":1024,"height":682,"url":"https:\/\/nawacita.co\/wp-content\/uploads\/2022\/02\/Sinopharm-Vacc.jpg","type":"image\/jpeg"}],"author":"redaksi","twitter_card":"summary_large_image","twitter_creator":"@nawacit4","twitter_site":"@nawacit4","twitter_misc":{"Written by":"redaksi","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nawacita.co\/index.php\/2022\/02\/02\/bpom-terbitkan-izin-penggunaan-vaksin-sinopharm-sebagai-vaksin-booster\/#article","isPartOf":{"@id":"https:\/\/nawacita.co\/index.php\/2022\/02\/02\/bpom-terbitkan-izin-penggunaan-vaksin-sinopharm-sebagai-vaksin-booster\/"},"author":{"name":"redaksi","@id":"https:\/\/nawacita.co\/#\/schema\/person\/599683af640858fd3b790bc37828ba57"},"headline":"BPOM Terbitkan Izin Penggunaan Vaksin Sinopharm Sebagai Vaksin Booster","datePublished":"2022-02-02T04:14:36+00:00","mainEntityOfPage":{"@id":"https:\/\/nawacita.co\/index.php\/2022\/02\/02\/bpom-terbitkan-izin-penggunaan-vaksin-sinopharm-sebagai-vaksin-booster\/"},"wordCount":283,"commentCount":0,"publisher":{"@id":"https:\/\/nawacita.co\/#organization"},"image":{"@id":"https:\/\/nawacita.co\/index.php\/2022\/02\/02\/bpom-terbitkan-izin-penggunaan-vaksin-sinopharm-sebagai-vaksin-booster\/#primaryimage"},"thumbnailUrl":"https:\/\/nawacita.co\/wp-content\/uploads\/2022\/02\/Sinopharm-Vacc.jpg","keywords":["BPOM","COVID-19","Terbitkan","vaksin booster","Vaksin Sinopharm"],"articleSection":["Nasional"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nawacita.co\/index.php\/2022\/02\/02\/bpom-terbitkan-izin-penggunaan-vaksin-sinopharm-sebagai-vaksin-booster\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nawacita.co\/index.php\/2022\/02\/02\/bpom-terbitkan-izin-penggunaan-vaksin-sinopharm-sebagai-vaksin-booster\/","url":"https:\/\/nawacita.co\/index.php\/2022\/02\/02\/bpom-terbitkan-izin-penggunaan-vaksin-sinopharm-sebagai-vaksin-booster\/","name":"BPOM Terbitkan Izin Penggunaan Vaksin Sinopharm Sebagai Vaksin Booster - Nawacita","isPartOf":{"@id":"https:\/\/nawacita.co\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nawacita.co\/index.php\/2022\/02\/02\/bpom-terbitkan-izin-penggunaan-vaksin-sinopharm-sebagai-vaksin-booster\/#primaryimage"},"image":{"@id":"https:\/\/nawacita.co\/index.php\/2022\/02\/02\/bpom-terbitkan-izin-penggunaan-vaksin-sinopharm-sebagai-vaksin-booster\/#primaryimage"},"thumbnailUrl":"https:\/\/nawacita.co\/wp-content\/uploads\/2022\/02\/Sinopharm-Vacc.jpg","datePublished":"2022-02-02T04:14:36+00:00","description":"Jakarta, Nawacita | Sinopharm resmi menjadi vaksin keenam yang digunakan untuk dosis booster atau penguat di Indonesia. Badan Pengawas Obat","breadcrumb":{"@id":"https:\/\/nawacita.co\/index.php\/2022\/02\/02\/bpom-terbitkan-izin-penggunaan-vaksin-sinopharm-sebagai-vaksin-booster\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nawacita.co\/index.php\/2022\/02\/02\/bpom-terbitkan-izin-penggunaan-vaksin-sinopharm-sebagai-vaksin-booster\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/nawacita.co\/index.php\/2022\/02\/02\/bpom-terbitkan-izin-penggunaan-vaksin-sinopharm-sebagai-vaksin-booster\/#primaryimage","url":"https:\/\/nawacita.co\/wp-content\/uploads\/2022\/02\/Sinopharm-Vacc.jpg","contentUrl":"https:\/\/nawacita.co\/wp-content\/uploads\/2022\/02\/Sinopharm-Vacc.jpg","width":1024,"height":682,"caption":"ilustrasi vaksin sinopharm"},{"@type":"BreadcrumbList","@id":"https:\/\/nawacita.co\/index.php\/2022\/02\/02\/bpom-terbitkan-izin-penggunaan-vaksin-sinopharm-sebagai-vaksin-booster\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nawacita.co\/"},{"@type":"ListItem","position":2,"name":"BPOM Terbitkan Izin Penggunaan Vaksin Sinopharm Sebagai Vaksin Booster"}]},{"@type":"WebSite","@id":"https:\/\/nawacita.co\/#website","url":"https:\/\/nawacita.co\/","name":"Nawacita","description":"Berita Kementerian, BUMN, Pemerintah dan Politik","publisher":{"@id":"https:\/\/nawacita.co\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nawacita.co\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/nawacita.co\/#organization","name":"Nawacita","url":"https:\/\/nawacita.co\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/nawacita.co\/#\/schema\/logo\/image\/","url":"https:\/\/nawacita.co\/wp-content\/uploads\/2021\/10\/Logo-Nawacita-2021.png","contentUrl":"https:\/\/nawacita.co\/wp-content\/uploads\/2021\/10\/Logo-Nawacita-2021.png","width":1676,"height":422,"caption":"Nawacita"},"image":{"@id":"https:\/\/nawacita.co\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/nawacitaco-1763136813898723\/?ref=aymt_homepage_panel","https:\/\/x.com\/nawacit4"]},{"@type":"Person","@id":"https:\/\/nawacita.co\/#\/schema\/person\/599683af640858fd3b790bc37828ba57","name":"redaksi","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a3ea3038dabe75a981e9a69b300b8272c74e0729c55e2f30478cde7add6c42f6?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a3ea3038dabe75a981e9a69b300b8272c74e0729c55e2f30478cde7add6c42f6?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a3ea3038dabe75a981e9a69b300b8272c74e0729c55e2f30478cde7add6c42f6?s=96&d=mm&r=g","caption":"redaksi"},"sameAs":["nawacitaportal","https:\/\/x.com\/nawacit4"],"url":"https:\/\/nawacita.co\/index.php\/author\/redaksi\/"}]}},"jetpack_featured_media_url":"https:\/\/nawacita.co\/wp-content\/uploads\/2022\/02\/Sinopharm-Vacc.jpg","_links":{"self":[{"href":"https:\/\/nawacita.co\/index.php\/wp-json\/wp\/v2\/posts\/127441","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nawacita.co\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nawacita.co\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nawacita.co\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nawacita.co\/index.php\/wp-json\/wp\/v2\/comments?post=127441"}],"version-history":[{"count":0,"href":"https:\/\/nawacita.co\/index.php\/wp-json\/wp\/v2\/posts\/127441\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nawacita.co\/index.php\/wp-json\/wp\/v2\/media\/127442"}],"wp:attachment":[{"href":"https:\/\/nawacita.co\/index.php\/wp-json\/wp\/v2\/media?parent=127441"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nawacita.co\/index.php\/wp-json\/wp\/v2\/categories?post=127441"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nawacita.co\/index.php\/wp-json\/wp\/v2\/tags?post=127441"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}